HF
COCH icon

HRT Financial’s Envoy Medical COCH Stock Holding History

HRT Financial’s Portfolio COCH Stock Details COCH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-123,388
Closed -$1.26M – 2479
2023
Q2 		$1.26M Buy
123,388
+700
+0.6% +$7.08K 0.01% 808
2023
Q1 		$1.23M Buy
122,688
+74,970
+157% +$751K 0.02% 840
2022
Q4 		$481K Sell
47,718
-3,639
-7% -$36.2K 0.01% 1456
2022
Q3 		$504K Buy
51,357
+409
+0.8% +$4.02K 0.01% 1491
2022
Q2 		$499K Buy
50,948
+182
+0.4% +$1.78K 0.01% 1560
2022
Q1 		$495K Sell
50,766
-391
-0.8% -$3.81K ﹤0.01% 1778
2021
Q4 		$498K Buy
+51,157
New +$499K ﹤0.01% 1809

Other funds holding COCH

AMC
Atlas Merchant Capital New York $585K AUM 83.95% 1-Year Est. Return
SIM
Sandia Investment Management Boston, Massachusetts $40.1M AUM 14.58% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.21B AUM 13.69% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.04B AUM 31.03% 1-Year Est. Return
CS
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return
RCM
Robinson Capital Management Grosse Pointe Farms, Michigan $226M AUM 6.92% 1-Year Est. Return
TI
Tidal Investments Milwaukee, Wisconsin $57.8B AUM 72.54% 1-Year Est. Return

HRT Financial's COCH Position: Q3 2023 in Review

HRT Financial sold out of Envoy Medical (COCH) in Q3 2023, closing a stake of 123,388 shares — an estimated $1.26M sold.

HRT Financial first reported a position in COCH in Q4 2021 and held it in 7 quarters. The position peaked at $1.26M in Q2 2023. 16 funds tracked by Wall St. Rank hold COCH as of Q3 2023.

  • HRT Financial reported no remaining Envoy Medical position as of Q3 2023 after selling out during the quarter.
  • HRT Financial sold 123,388 Envoy Medical shares in Q3 2023, an estimated $1.26M.
  • HRT Financial first reported a position in Envoy Medical in Q4 2021 and held it in 7 quarters.
  • HRT Financial's Envoy Medical position peaked at $1.26M in Q2 2023.
  • 16 funds tracked by Wall St. Rank held Envoy Medical as of Q3 2023.

Based on HRT Financial's 13F filing for Q3 2023, filed 13 Nov 2023.